Low‐Dose Naltrexone to Prevent Intolerable Morphine Adverse Events: A Forgotten Remedy for a Neglected, Global Clinical Need

Publisher： John Wiley & Sons Inc

E-ISSN： 1526-4637|16|6|1239-1242

ISSN： 1526-2375

Source： PAIN MEDICINE, Vol.16, Iss.6, 2015-06, pp. : 1239-1242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-dose CT in clinical diagnostics

By Fuentes-Orrego Jorge M   Sahani Dushyant V  

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 5, 2013-09 ,pp. : 501-510

Informa Healthcare

Access to resources Recommend Favorite

Addressing Postdischarge Adverse Events: A Neglected Area

By Tsilimingras Dennis   Bates David Westfall  

Joint Commission Journal on Quality and Patient Safety, Vol. 34, Iss. 2, 2008-02 ,pp. : 85-97

Joint Commission Resources

Access to resources Recommend Favorite

Do we Need a New Procedure for the Assessment of Adverse Events in Anti-migraine Clinical Trials?

By  

Recent Patents on CNS Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 41-47

Bentham Science Publishers

Access to resources Recommend Favorite

Age‐ and Gender‐Related Use of Low‐Dose Drug Therapy: The Need to Manufacture Low‐Dose Therapy and Evaluate the Minimum Effective Dose

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 47, Iss. 8, 1999-08 ,pp. : 954-959

John Wiley & Sons Inc

Access to resources Recommend Favorite

The strength of evidence: low dose morphine for chronic breathlessness

By  

INTERNAL MEDICINE JOURNAL, Vol. 48, Iss. 1, 2018-01 ,pp. : 102-103

John Wiley & Sons Inc

Access to resources Recommend Favorite